Recophus CR Tablet (Levodropropizine)

Adult dose

Adults: Take 1 tablet per dose (equivalent to 90mg of levodropropizine) orally 2 times daily. This medicine is an extended-release formulation; swallow it whole without splitting or crushing it.

This medication should not be used by certain patients. First, individuals who are allergic to this medication or any of its ingredients should avoid taking it. It is also advisable not to use this medication in individuals with excessive bronchial mucus secretion. Patients with ciliary dysfunction, such as those with Kartagener syndrome or immotile cilia syndrome, should not take this medication. Women who are pregnant, may become pregnant, or are breastfeeding should also refrain from using this medication. Individuals with severe liver dysfunction should avoid taking this medication as well. In addition, since this medication contains lactose, individuals with lactose intolerance, galactose intolerance, or genetic lactose metabolism disorders should exercise caution. This medication should be administered cautiously to patients with severe heart failure or very poor kidney function, elderly individuals, and children. In particular, in the case of children, it is recommended to use a different formulation that allows for divided dosing instead of this controlled-release formulation. Some side effects may occur when using this medication. For example, gastrointestinal system side effects may include nausea, dyspepsia, and constipation, which are rarely reported. Central nervous system side effects may include drowsiness, headache, and dizziness, which can occur frequently or rarely. Additionally, swelling around the ears or eyes and dizziness may occur. Transient elevations in liver function test results have also been reported. Precautions should be taken when driving or operating machinery while taking this medication. In particular, when taken with alcohol, symptoms such as drowsiness or dizziness may be exacerbated. Careful consideration is also needed when used in conjunction with sedatives. This medication should be stored out of the reach of children in a safe place, and it is advisable to keep it in its original container as transferring it to another container may affect its quality.

• Area
• dyspepsia
• constipation
• drowsiness
• headache
• dizziness
• positional vertigo
• eyelid edema
• increased urinary leukocytes
• elevated ALT

This medication is easily affected by air and moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius. By doing so, the effectiveness and safety of the medication can be preserved for a longer period.

Appearance

A rectangular controlled-release tablet consisting of a white to light yellow upper layer and a white lower layer.

Package unit

30 tablets/bottle, 300 tablets/bottle